Results 181 to 190 of about 137,565 (249)

Neonatal pleural effusions in a level III Neonatal Intensive Care Unit [PDF]

, 2015
Mariana Marques Barbosa
core  

Evaluation of biomarkers sTREM-1, procalcitonin and C reactive protein in the diagnosis of pleural infection. [PDF]

BMJ Open Respir Res
Alvarenga VA, Teixeira LR, Sales RKB, Colares PFB, Silva CSR, Marchi E, Acencio MMP.   +6 more
europepmc   +1 more source

Management of Severe Respiratory Failure after Acute Empyema Surgery in a Patient with Down Syndrome: A Case Report. [PDF]

Surg Case Rep
Ichinohe C, Tani K, Kimura D, Matsuo T, Sasaki T, Kimura S, Minakawa M.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Parapneumonic Effusion and Empyema

Clinics in Chest Medicine, 2021
The rising incidence and high morbidity of pleural infection remain a significant challenge to health care systems worldwide. With distinct microbiology and treatment paradigms from pneumonia, pleural infection is an area in which the evidence base has been rapidly evolving.
Dinesh N, Addala, Eihab O, Bedawi, Najib M, Rahman   +2 more
openaire   +3 more sources

Diagnosis of pleural empyema/parapneumonic effusion by next-generation sequencing

Infectious Diseases, 2021
Background Although a microbiological diagnosis of pleural infection is clinically important, it is often complicated by prior antibiotic treatment and/or difficulties with culturing some bacterial species.
Y. Shiraishi, K. Kryukov, K. Tomomatsu, F. Sakamaki, S. Inoue, S. Nakagawa, T. Imanishi, K. Asano   +7 more
semanticscholar   +3 more sources

Diagnostic value of soluble biomarkers for parapneumonic pleural effusion

Critical Reviews in Clinical Laboratory Sciences, 2023
Parapneumonic pleural effusion (PPE) is a common complication in patients with pneumonia. Timely and accurate diagnosis of PPE is of great value for its management.
Xinping Cao, Wenguang Zheng, Zhi-De Hu
semanticscholar   +3 more sources

Conservative and Surgical Modalities in the Management of Pediatric Parapneumonic Effusion and Empyema: A Living Systematic Review and Network Meta-Analysis.

Chest, 2023
BACKGROUND The optimal treatment for community-acquired childhood pneumonia complicated by empyema remains unclear. RESEARCH QUESTION In children with parapneumonic effusion or empyema, do hospital length of stay and other key clinical outcomes differ ...
Clara Fernandez Elviro, Bryn Longcroft-Harris, E. Allin, L. Leache, Kellan Woo, J. Bone, Colleen Pawliuk, Jalal Tarabishi, Matthew Carwana, M. Wright, Nassr Nama, Roshan A. Ananda, Priyadharshini Ramakrishnan, Tala J. Alhejazi, Alyssa Y. Chen, Amin Sharifan, M. M. Shawqi   +16 more
semanticscholar   +1 more source

Evaluation of the efficiency of the systemic immune‐inflammation index in differentiating parapneumonic effusion from empyema

Pediatric Pulmonology, 2022
To evaluate the effectiveness of the systemic immune‐inflammation index (SII) and other biomarkers in distinguishing parapneumonic effusion (PPE) and empyema.
M. M. Güneylioğlu, A. Güngör, A. Göktuğ, Ç. Üner, İ. Bodur, R. Yaradılmış, B. Öztürk, Z. Şen, N. Tuygun   +8 more
semanticscholar   +1 more source

Intrapleural thrombolytics for parapneumonic effusion: A network meta-analysis.

Current Reviews in Clinical and Experimental Pharmacology, 2022
OBJECTIVES Intrapleural thrombolytics have been trialed for facilitating pleural fluid drainage in patients with complicated parapneumonic effusion. The present study is a network meta-analysis of randomized clinical trials (RCTs) that have evaluated ...
K. Sridharan, G. Sivaramakrishnan
semanticscholar   +1 more source